Sponsor Pipeline

Restore Biologics Holdings, Inc. dba Xtressé Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
0
Recruiting
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07482423
XVIE to Treat Androgenetic Alopecia (AGA)
date change Primary completion pushed: 2027-05-01 -> 2028-05-01
2026-08-13 NCT07482423
XVIE to Treat Androgenetic Alopecia (AGA)
date change Completion pushed: 2027-05-01 -> 2028-05-01
Active Trials by Phase
Phase 1/2
1
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07482423 XVIE to Treat Androgenetic Alopecia (AGA) Androgenetic Alopecia Not Yet Recruiting
Not specified
NCT07221773 Pilot Study to Evaluate the Efficacy and Safety of Xvie Delivered Into the Scalp by… Hair Thinning Enrolling by Invitation
NCT07224555 Study Evaluating Xtressé Gummy Supplement in Women With Self-Perceived Thinning Hair Hair Thinning Enrolling by Invitation
NCT07228156 Study to Evaluate Xtresse Serum in Individuals With Thinning Hair Thin Hair Active, Not Recruiting
NCT07637071 Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia Androgenic Alopecia Not Yet Recruiting
Get alerts when Restore Biologics Holdings, Inc. dba Xtressé's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free